Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Summary
This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.
Official title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Aripiprazole as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
1200
Start Date
2004-06
Completion Date
2006-08
Last Updated
2026-10-13
Healthy Volunteers
No
Conditions
Interventions
Antidepressant + Placebo
Antidepressant Caps/Tablets Placebo Tablets, Oral, 2-20 mg Placebo, once daily, 6 weeks following an 8 week Prospective Treatment (Baseline) Phase.
Antidepressant + Aripiprazole
Antidepressant Caps/Tablets Aripiprazole Tablets, Oral, 2-20 mg Aripiprazole, once daily, 6 weeks following an 8 week Prospective Treatment (Baseline) Phase.
Locations (20)
Local Institution
Garden Grove, California, United States
Local Institution
Northridge, California, United States
Local Institution
Washington D.C., District of Columbia, United States
Local Institution
Jacksonville, Florida, United States
Local Institution
Chicago, Illinois, United States
Local Institution
Edwardsville, Illinois, United States
Local Institution
Rockville, Maryland, United States
Local Institution
Springfield, Massachusetts, United States
Local Institution
Farmington Hills, Michigan, United States
Local Institution
Okemos, Michigan, United States
Local Institution
Staten Island, New York, United States
Local Institution
Portland, Oregon, United States
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution
Austin, Texas, United States
Local Institution
Salt Lake City, Utah, United States
Local Institution
Woodstock, Vermont, United States
Local Institution
Charlottesville, Virginia, United States
Local Institution
Bellevue, Washington, United States
Local Institution
Seattle, Washington, United States
Local Institution
Middleton, Wisconsin, United States